Kanghui Medical's 20-Year Globalization Journey: Empowering Global Healthcare Accessibility through Supply Chain Globalization

Xinhua News Agency, Deqing, May 9th, by reporter Qilong Wu – On May 9th, the "2025 Brand High-Quality Overseas Expansion Forum," hosted by Xinhua News Agency and the New Media Center of Xinhua News Agency, was held in Deqing, Zhejiang.

From "Pioneer of Going Global" to a Global Benchmark: 20 Years of Dedication to Building Full-Chain Capabilities

Public information shows that Kanghui Medical was established in 1997 and officially entered the international market in 2005. To date, it has been deeply engaged in the global market for 20 years. As a high-tech enterprise focusing on orthopedic implant consumables and intelligent equipment, the company aims for "Made in China, Globally Shared," building comprehensive global capabilities covering research and development, manufacturing, registration, and sales.

According to reports, up to now, Kanghui's medical products have entered more than 65 countries and regions worldwide, passed medical regulatory approvals in over 40 countries and regions including the EU CE, Japan PMDA, and Brazil ANVISA, and obtained more than 600 international authoritative certifications. They provide medical solutions that combine clinical effectiveness with economic accessibility for emerging markets in the Asia-Pacific, Africa, Central and Eastern Europe, and Latin America. In the forum’s unveiled "2025 Typical Cases of Brand Exporting," Kanghui was selected as a "Typical Case of Supply Chain Globalization" due to its practice of globalizing its supply chain.

Three Core Advantages and Strategic Support: Building a Resilient Supply Chain System

In the global layout of the supply chain, Kanghui Medical has formed three core advantages: First, optimizing global production nodes. In 2023, the Medtronic Kanghui Changzhou Science and Technology Park will be fully upgraded to create a strategic platform integrating intelligent manufacturing, excellent R&D, innovative incubation, and customer experience. Relying on the advantages of China's manufacturing cluster, it realizes rapid product iteration and global supply.

Medtronic Kanghui Changzhou Science Park

Second, establish a localized procurement and supplier network, develop material receiving standards in line with international norms, and enhance supply chain resilience to address fluctuations in global logistics and raw materials.

Third, align with international quality systems, obtain ISO 13485 certification, integrate the regulatory requirements of China NMPA, U.S. FDA, and EU MDR, and establish a new benchmark for "Quality Made in China."

Based on the aforementioned advantages, Kanghui Medical implements three key strategies: "expanding regional coverage, broadening the product pipeline, and focusing on academic exchange." In terms of regional coverage, by leveraging local distribution channels, participating in international exhibitions such as Arab Health, and engaging in academic exchanges along the "Belt and Road," Kanghui promotes Chinese orthopedic products into mainstream clinical settings in regions like Southeast Asia and Central and Eastern Europe.

In terms of product pipeline, the company has expanded from traditional orthopedic consumables to intelligent devices, launching high-end products such as intraoperative neuromonitoring systems and orthopedic surgical robots. In 2023, strategic cooperation with Beijing Jishuitan Hospital and Rosun Robotics accelerated the "industry-university-research-medical" collaboration. Notably, the Omnail Femoral Intramedullary Nail System won the German Design Award, achieving coverage in 11 countries within two years and a fourfold increase in business volume.

Omnail™ Wins 2023 German Design Award

In terms of academic exchange, technology is disseminated through regional academic summits and clinical training, promoting the global recognition of Chinese medical standards.

From "Going Out" to "Moving Up": Building a Sustainable Supply Chain Ecosystem

Kanghui's globalization practices focus not only on product delivery but also on the construction of localized industrial ecosystems. On the manufacturing side, the intelligent upgrade of Medtronic Kanghui's Changzhou Science and Technology Park has achieved automated and informatized production, ensuring stable and efficient global supply. In terms of social responsibility, public welfare activities such as spinal health screenings and patient education have been carried out in places like India and Colombia, fulfilling the commitment to "rooted locally, serve locally."

Case review experts pointed out that Kanghui Healthcare has responded to the international market's demand for accessible quality healthcare through "local innovation + global standards." As the "Healthy China" and "Belt and Road" initiatives advance, Kanghui Healthcare, with the globalization of its supply chain as a link, is promoting the integration of China’s supply chain with international standards. It provides the industry with a replicable "going global template," demonstrating its capability to contribute to the construction of global healthcare resilience.

From May 9 to 11, 2025, the World Brand Moganshan Conference was held in Deqing, Zhejiang. The World Brand Moganshan Conference was co-founded by the Xinhua News Agency Brand Office, China National Brand Network, and others, and has been successfully held for two consecutive sessions prior to this. As one of the key events of the 2025 World Brand Moganshan Conference, the "2025 High-Quality Brand Overseas Expansion Forum" focused on the theme of "New Challenges, New Opportunities, New Pathways," bringing together insights from all parties to collectively explore diversified development paths for brand internationalization.